A rising challenge: Polysubstance use in older adults
For older adults, substance use disorders (SUD) are often overlooked or misdiagnosed, mistaken for symptoms of aging or other medical conditions. This diagnostic challenge is compounded when dealing with polysubstance use, particularly for those with opioid use disorder (OUD). The interaction between opioids and other substances can be especially dangerous in an aging body, which often has reduced drug metabolism, heightened sensitivity, and pre-existing health issues.
Alcohol: The leading co-occurring substance
Several studies indicate that alcohol use disorder consistently ranks as the most common co-occurring substance use disorder among older adults with an existing OUD. This high prevalence can be attributed to several factors, including social and emotional triggers, long-standing habits, and accessibility.
The deadly synergy of alcohol and opioids
When combined, alcohol and opioids—both central nervous system depressants—create a heightened risk of serious health consequences, including fatal overdose, increased risk of accidents, and exacerbation of medical conditions.
Benzodiazepines: The second most prevalent co-occurring substance
Following alcohol, the misuse of benzodiazepines, such as alprazolam, lorazepam, and diazepam, is the second most common co-occurring substance use disorder in older adults with OUD. This specific comorbidity is largely linked to the high rates of prescription benzodiazepines among seniors for conditions like anxiety and insomnia.
The prescription factor and heightened risks
Combining opioids and benzodiazepines creates additive sedative effects, significantly increasing the risk of overdose, respiratory failure, and cognitive and functional decline. This combination can also complicate withdrawal.
Screening and diagnosis challenges
Diagnosing polysubstance use in older adults is complex due to the overlap of symptoms with other health conditions, social stigma, and the management of multiple prescriptions. Standardized questionnaires, urine drug screens, and an interdisciplinary evaluation can aid in identification.
Understanding the spectrum of co-occurring disorders
Beyond alcohol and benzodiazepines, other substances can be involved in co-occurring disorders in older adults. The following table provides a comparison of common co-occurring substances and their associated risks in older adults with OUD.
Substance | Primary Mode of Acquisition | Key Risk with Opioids in Older Adults |
---|---|---|
Alcohol | Legal access, lifelong habit | Respiratory depression, liver damage, fatal overdose, falls |
Benzodiazepines | Frequent prescriptions for anxiety/sleep | Severe respiratory depression, cognitive decline, addiction |
Cannabis | Recreational or medicinal use | Increased sedation, cognitive effects, drug interactions |
Stimulants | Diverted prescriptions, illicit sources | Cardiovascular strain, heart attack, stroke, psychological effects |
Integrated treatment strategies for older adults
Effective treatment for OUD with co-occurring SUDs in older adults requires a specialized and integrated approach. This includes comprehensive assessment, careful medication management (including MAT), and behavioral therapies like CBT and Motivational Interviewing.
The importance of a supportive environment
For many older adults, recovery is heavily influenced by their living situation and social connections. Addressing issues like isolation, grief, and housing stability is a crucial part of the recovery process. Integrated care, including mental health and social work services, is vital to providing holistic support. For more resources on aging and mental health, the National Institute on Aging offers comprehensive information and research (https://www.nia.nih.gov/).
Conclusion
Alcohol use disorder is the most common co-occurring substance use disorder among older adults with OUD, followed by the misuse of benzodiazepines. These combinations pose significant health risks. Effective care requires recognizing this complexity and providing integrated treatment that addresses all dependencies, comorbidities, and psychosocial factors to improve outcomes and quality of life.